Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

Please watch the video at Investors.com - How Novo Nordisk, Wegovy And Ozempic Are Changing The Weight ... Madrigal's ability ...

On Monday, Ascendis Pharma A/S (NASDAQ:ASND) granted Novo Nordisk A/S (NYSE:NVO) an exclusive worldwide license. The pact ...

Novo Nordisk, the maker of Ozempic, reported that compounded versions of semaglutide, the main ingredient in Ozempic and Wegovy, have led to at least 100 hospitalizations and 10 deaths.

Novo Nordisk, the company behind Ozempic and Wegovy, is now Europe's largest company as global demand for its drugs have soared. But the Danish pharmaceutical company's origins were motivated by ...

Novo Nordisk is lifting curbs on prescriptions of its weight-loss drug Wegovy in the United States and is increasing supply ...

GLP-1 agonist Wegovy (semaglutide) brought in DKK 17.3 billion ($2.49 billion) in the period, restoring earlier levels of ...

Ozempic and Wegovy may not have been developed if not for the insistence of Novo Nordisk's head of research, Mads Krogsgaard. Leadership at the Danish company in the early 1990s were skeptical ...

Wegovy is a weight loss medication that you can only get with a prescription from a licensed healthcare professional. Learn more about who is eligible and what to expect at your initial ...